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capsid protein of FPV and that against annexin 33 kDa were obtained 
from Drs Becht and Lim as previously described [2]. Anti-annexin V 
Abstract Influenza viruses bind to annexin V, a widely spread antiserum was produced in a rabbit by immunizing with 50 ~g of 
non-glycosylated phospholipid-binding protein. Externally added annexin V in the presence of Freund's adjuvant at monthly intervals 
phospholipids as well as antiserum against this protein specifi- over a period of 2 months. The highest antibody titer obtained was 
cally inhibit infection of these viruses in cell cultures. We about 1:500 as determined by ELISA. Immunostaining of the virus 
conclude that annexin V plays an important role in the entry of specific nucleocapsid protein (NP) in the nuclei of infected cells was 
these viruses, performed 2 h after virus infection. 
2.3. Phospholipids 
Key words: Influenza virus; Binding protein; Receptor; All phospholipids u ed were Sigma grade pure compounds with the 
Annexin; Phospholipid indicated catalogue numbers: phosphatidic acid (P-9511), phosphati- 
dylcholine (P-3556), phosphadidylethanolamine (P-6386), phosphati- 
dylinositol (P-5766), phosphatidylserine (P-7769) and sphingomyelin 
(S-7004). Phospholipids were added into the culture medium as clear 
1. Introduction suspensions of primarily unilamellar liposomes, using the ethanol in- 
jection method of Batzri and Korn [9]. For each phospholipid a stock 
In the initial step of influenza virus infection, sialic acid (N- solution was prepared in warm (37°C) ethanol at the concentration f 
acetylneuraminic acid) on the cell surface is generally thought 10 mM. Just before experiments, he indicated portions of this stock 
solution were taken up with an Eppendorf micropipette and rapidly 
to be the only binding site and receptor for the virus (reviewed injected into the culture medium. In all cases, the culture medium 
in [1]). However, we recently found a sialic acid-free protein in remained optically clear after the addition of phospholipids. 
several cell lines, that clearly binds influenza A and B viruses 
[2]. This protein also binds phospholipids and has an apparent 
molecular mass of 33 kDa, suggesting that it is a member of a 3. Results and discussion 
class of structurally homologous proteins, annexins I-V [3-7], 
that are known to bind phospholipids and possess very close Fig. 1 shows that FPV binds to annexin V at the position of 
molecular masses. We report here that a purified recombinant 33 kDa. The results obtained with PR8 and Singapore were 
human annexin V, exhibiting a molecular mass of 33 kDa is the same (not shown). These findings indicate that annexin V
equally capable of binding influenza viruses: fowl plaque binds these viruses and that it probably corresponds to the 33 
virus, PR8 and Singapore. This shows that the 33 kDa kDa virus-binding protein we found previously [2]. The cru- 
virus-binding protein we found probably corresponds to an- cial question is whether binding of influenza virus to annexin 
nexin V. Further experiments showed that infection of influ- V (or annexin 33 kDa) is an essential step for infection. An- 
enza viruses could be inhibited by externally added phospho- nexins are thought o be both intracellular and plasma mem- 
lipids as well as by antiserum against annexin V. These results brane components [10-12]. If the binding of viral phospholi- 
substantiated our view that annexins may serve as a second pids to the annexins of the plasma membrane is an essential 
receptor for these viruses, step for infection, externally added phospholipids should com- 
pete in this reaction, resulting in the inhibition of virus infec- 
2. Materials and methods tion. This rationale was tested with MDCK (Madin-Darby 
canine kidney) cells that were infected with the viruses FPV, 
2. I. Culture cell, viruses and annexin V PR8 and Singapore in the presence or absence of phospholi- 
Continuous MDCK (Madin Darby canine kidney) cells originally pids. Fig. 2 shows typical results obtained with phosphatidyl- 
obtained from the American Type Culture Collection, were grown to 
confluency in Dulbecco's medium containing 10% calf serum. Influ- ethanolamine (PE), a major phospholipid of the viral envelope 
enza virus strains fowl plaque virus (FPV; A/Rostock; Havl, N1), PR [13]. At the virus input of 50 plaque forming units (pfu), the 
8 (A/PR/8; HO, N1) and Singapore (MSingapore/6/86; HI, N1), were virus yield at the end of an 8 h reproduction cycle was in- 
infected in these cells as described previously [2]. Recombinant annex- hibited progressively by PE at concentrations between 0.1 and 
in V was obtained from Serva, Heidelberg (rh annexin V, cat. no. 
0.3 mM. When the virus input was elevated to 100 and 200 BMF 306). Virus binding was detected by an overlay technique [8]. 
Annexin V was electrophoresed in an SDS-polyacrylamide geland pfu, PE became less effective at these concentrations. When 
then blotted on nitrocellulose (Schleicher and Schtill: BA 85, 0 .45  infection time was prolonged to 24 h, virus infection could be 
~tm, No. 401396) and exposed to FPV. The position of virus binding partially restored even in the presence of PE. These results 
was visualized by immunostaining of the viral hemagglutinin asde- clearly indicate that PE competitively inhibited virus infection 
scribed before [2]. 
in a dose- and time-dependent manner. All phospholipids 
2.2. Antibodies and immunostaining were found to inhibit virus infection. However, phosphatidyl- 
Monoclonal antibodies against he hemagglutinin a d the nucleo- ethanolamine, phosphatidylserine, phosphatidylinositol and 
phosphatidic acid were more effective, needing only about 
*Corresponding author. Fax: (49) (30) 838 4802. one half to one third the concentrations of phosphatidylchol- 
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............. ........... shows that there was complete inhibition of NP synthesis 2 h 
after infection, when PE was present in the medium. 
-4= 1 9 0 In further experiments anti-annexin V antiserum was used 
to determine whether annexin V is localized on the surface of 
-~ ] ] 6 cells and whether this antibody can block virus-binding, re- 
sulting in inhibition of virus infection. This serum was found 
to react with monolayers of MDCK cells and elicited plasma 
-'~ 84  membrane fluorescence after treatment with FITC-labelled 
anti-rabbit IgG, indicating the presence of annexin V on the 
surface of these cells (not shown). This is in accord with re- 
-4, 58 
ports that annexins are intracellular as well as plasma mem- 
-.~ 4 8 brane components [10-12]. To test the effect of anti-annexin V 
antiserum on virus multiplication, it was added to cells before 
viruses were given and the cells were maintained in the con- 
stant presence of this antiserum. Virus infection was ascer- 
tained by immunofluorescence detection of the early virus- 
-4  3 6 specific NP in the same manner as described before [14]. It 
was found that NP synthesis was greatly suppressed at 1:20 
-.~ 2 6 and 1:40 antiserum dilutions. In contrast, pre-immune serum 
.... did not show this effect (Table 1). 
All the above results ubstantiated the view that annexin V; ! i i  
. . . . . . . .  is needed for influenza virus infection, probably as a second 
receptor. Influenza viruses possess spikes of hemagglutinin 
A B and neuraminidase in their envelope [15]. The hemagglutinin 
Fig. 1. Binding of influenza virus FPV to annexin V on nitrocellu- binds to the first receptor, sialic acid, when the virus initially 
lose. Annexin V was separated alongside with stained molecular encounters the cell. Reaction with annexin probably occurs 
weight markers in an SDS-polyacrylamide gel (10%), blotted onto after the virus is drawn to its proximity by sialic acid. Annex- 
nitrocellulose and overlaid with the virus. (A) Annexin V; (B) mole- 
cular weight markers in kDa on the right, ins have been reported to fuse membranes atneutral pH [16]. 
This occurs by a different mechanism than the acid-triggered 
fusion mediated by influenza virus hemagglutinin [17]. Influ- 
enza viruses are widely believed to fuse in the acidic environ- 
ine and sphingomyelin for the complete inhibition of infection ment of endosomes [18]. However, another view favours the 
(Table 1). This is in accordance with the known binding spec- fusion of these viruses with the plasma membrane at neutral 
ificity of annexins to various phospholipids [6]. The suppres- pH [19]. In the latter case, annexins could participate in the 
sion of virus infection by phospholipids could also be demon- fusion process. It is of interest o note that other enveloped 
strated early by the absence of virus-specific nucleocapsid viruses have also been shown to use annexins as receptors: 
protein (NP) synthesis when phospholipids were present in Hepatitis B virus [20] and human cytomegalovirus [21] react 
the medium during the entry phase of the viruses: Fig. 3 respectively with annexins V and II. It remains to be estab- 
I virus input: 50 pfu virus input: 100 pfu I virus input: 200 pfu 
I 
I 64- 64- 64. 
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Fig. 2. Competitive inhibition of influenza virus (FPV) infection by phosphatidylethanolamine (PE) in MDCK cells. (Filled bars) Virus yield 
obtained 8h after infection and (hatched bars) virus yield obtained 24 h after infection. Virus yield is shown as cell-associated hemagglutinating 
units measured after three cycles of freeze-thawing. PE was added as very fine unilamellar liposomes. 
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Fig. 3. Inhibition of viral nucleocapsid protein (NP) synthesis by PE. (A) Positive test for NP in the nuclei of cells in the control. (B) Negative 
test for NP in the nuclei of PE supplemented sample. MDCK cells were covered in Dulbecco's medium, supplemented or unsupplemented with 
PE (0.3 mM), and infected with FPV at an input of 50 pfu for 2 h. Dishes were fixed with methanol, treated with a monoclonal antibody 
against NP and stained with a fluorescein-labelled anti-mouse IgG. 
Table 1 
Inhibition of FPV infection in MDCK cells by various supplementations i  the culture medium 
Supplementation in medium Dilution Concentration (mM) % infected cells b 
PA, PS, PI, PE 0.1-0.2 0 
PC, Sphm a 0.4-0.6 0 
Pre-immune serum 1:20-1:40 100 
Anti-annexin V antiserum 1:20-1:40 0~10 
1:80-1:160 10-100 
aPA, phosphatidic acid; PS, phosphatidylserine; PI, phosphatidylinositol; PE, phosphatidylethanolamine; PC, phosphatidylcholine; Sphm, sphin- 
gomyelin. 
bEstimated by counting the numbers of NP-positive and NP-negative ceils in a microscopic field. 
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